Restart Life Sciences News and Activities

Restart Life Sciences is a company listed under the stock ticker NOVA (CA).

View the org chart displaying its 6 main executives

Most searched biographies at Restart Life Sciences

• Steve Loutskou, Chairman of the Board, President and Chief Executi...
• Georg Hochwimmer, Director
• Khavita Harrycharran, Director

Popular executive movements at Restart Life Sciences

• Rebecca Hudson, Chief Financial Officer, has left the company  (posted on June 3 2026).
• Inez Ho has joined the company as Chief Financial Officer  (posted on June 3 2026).

Create your alert
to follow the executive moves at Restart Life Sciences.

Restart Life Sciences has 3,493 competitors including UnitedHealth Group (United States (USA)), Kaiser Permanente (United States (USA)) and HCA (United States (USA)).

Popular M&A news in Healthcare

• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Freeman Health System has acquired Northwest Health (posted on June 2 2026).
• Garner Health has just announced a $100 Million fundraising (posted on May 29 2026).

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Gregory Adams - Chief Executive Officer and Chairman of the Board at Kaiser Permanente
• Pablo Legorreta - Chairman of the Board, Founder and Chief Executive Officer at Royalty Pharma

Learn more about the Healthcare industry

Press releases by Restart Life Sciences

• Nova Mentis Assigns Intellectual Property
• Participant Screening Underway in Canada’s First Psilocybin Clinical Trial for Fragile X Syndrome
• Participant Screening Underway in Canada’s First Psilocybin Clinical Trial for Fragile X Syndrome
• Participant Screening Underway in Canada’s First Psilocybin Clinical Trial for Fragile X Syndrome
• Nova Mentis to Enter mRNA AI Diagnostics Business
• Nova Mentis Begins Recruitment in First-of-its-Kind Health Canada Psilocybin Trial
• Nova Mentis Receives Institutional Review Board Approval to Commence Psilocybin Clinical Trial
• Nova Mentis Provides Corporate Update and 2023 Outlook
• Nova Mentis Appoints Derek Ivany as Executive Chairman
• Nova Mentis Granted Health Canada Section 56 Exemption to Begin Psilocybin Clinical Trial
• View more press releases Close

Social media about Restart Life Sciences

• Restart Life Sciences on Wikipedia, Google News & Yahoo Finance
• Restart Life Sciences on LinkedIn, X (Twitter) & YouTube